جميع الدراسات
التوظيفالمرحلة 2، المرحلة 3تدخلي

Study of Dapansutrile Tablets in Subjects With an Acute Gout Flare

If you're experiencing a sudden, very painful flare-up of gout, this research study might be for you. It's testing a new tablet called dapansutrile to see if it can safely and effectively ease the pain and swelling of acute gout attacks. We're looking for adults aged 18 and over who have had a gout flare-up recently. Some participants will receive the new tablet, while others will get a placebo (a dummy tablet) to help us understand the treatment's true effects. The study plans to involve up to 300 people and will last for about five weeks, including several clinic visits to monitor your progress and ensure your safety.

نظرة سريعة

الحالة
التوظيف
المرحلة
المرحلة 2، المرحلة 3
الراعي
Olatec Therapeutics LLC
الهدف من التسجيل
300
ابدأ
06 Jan 2023
التاريخ المتوقع للانتهاء
31 يناير 2027

ما هو موضوع هذه الدراسة؟

Gout is a type of arthritis that causes sudden, severe attacks of pain, redness, and swelling in the joints, often starting in the big toe. These attacks, known as gout flares, can be very unpleasant. This research study is looking at a new tablet called dapansutrile, which scientists think might help reduce the inflammation and pain during these attacks. The main goal is to find out if this new tablet is effective and safe for people experiencing a gout flare.

The study is designed to be very careful and fair. It's a 'Phase 2/3' study, which means it's a later stage of research and we're looking closely at how well the treatment works and its side effects. Some people taking part will receive the new dapansutrile tablet, and others will get a 'placebo' tablet, which looks the same but contains no active medicine. This comparison helps us understand if any improvements are genuinely due to the new tablet or something else. Neither you nor your study doctor will know whether you're getting the active drug or the placebo, to keep the results as unbiased as possible.

We are looking for up to 300 adults who are currently having a gout flare. Participants will take their assigned tablets twice a day for seven days. Doctors and nurses will check in with you regularly to see how you're feeling, if the pain is improving, and to make sure you are safe. This information will help us decide if dapansutrile could be a useful new treatment for people with gout flares in the future.

النقاط الرئيسية

  • This study is testing a new tablet for painful gout attacks.
  • It aims to find out if the new tablet (dapansutrile) is safe and effective.
  • Some participants will get the new tablet, others a dummy tablet (placebo).
  • You'll take tablets for 7 days and have clinic visits over about 5 weeks.
  • You will not be able to use your usual pain relief during the study, but rescue medication will be provided.
  • المشاركة طوعية، ويمكنك الانسحاب في أي وقت.

من قد يكون مؤهلاً؟

To be considered for this study, you need to be at least 18 years old. You must have a clear diagnosis of gout, and importantly, you need to be experiencing an active gout flare-up that started within the last four days.

There are some reasons why you might not be able to join. For example, if you have more than three joints affected by gout at the moment, or if you have any other types of severe arthritis like rheumatoid arthritis. We also can't include you if you have signs of an infection in your joint, or if you have other serious pain that would make it hard to tell if the gout treatment is working.

Also, if you have severe kidney problems, certain serious illnesses, or recent cancer treatment, this study might not be suitable. It's crucial that you don't have an allergy to the study medication or to paracetamol, and that you or your doctor aren't planning to use certain other medications that might interfere with the study treatment.

هل يمكن أن تناسبك هذه الدراسة؟

أجب عن هذه الأسئلة السريعة لترى ما إذا كنت مؤهلاً. هذا دليل فقط - الفريق البحثي هو الذي يتخذ القرار النهائي.

  1. هل عمرك 18 سنة أو أكثر؟
  2. Have you been diagnosed with gout?
  3. Are you currently having a gout flare that started within the last 4 days?
  4. Do you have no more than 3 joints affected by gout right now?
  5. Do you have no severe kidney disease or other serious health issues identified by the study doctor?
  6. Are you able to attend clinic appointments for about 5 weeks?
أجب عن كل سؤال لترى نتيجتك.

ماذا يتضمن المشاركة؟

If you choose to take part, you'll first have a screening visit to make sure the study is right for you. If you qualify, you'll be given either the dapansutrile tablet or a placebo tablet to take twice a day for seven days. The study treatment is provided as an initial larger 'loading dose' on the first day, followed by smaller, regular doses.

During the study, you'll need to return to the clinic for check-ups. You'll have a visit on Day 4 while you're still taking the medication, and then after you've finished the seven days of treatment, you'll have follow-up visits on Day 8 and Day 15. The research team will continue to collect information about your safety up to Day 36. During the main treatment period, you won't be able to take other pain medicines, anti-inflammatory drugs (like steroids or NSAIDs), or most other gout treatments, but you will be given 'rescue medication' if your pain becomes unmanageable.

المخاطر والفوائد المحتملة

Taking part in a clinical trial has its potential benefits and risks. You might benefit from receiving a new treatment that could help your gout flare, and you'll be closely monitored by healthcare professionals. However, there's no guarantee that the treatment will work for you, and because some people receive a placebo, your symptoms might not improve. There's also a chance you could experience side effects from the study medication, some of which might be unknown. You are free to withdraw from the study at any time, for any reason, without it affecting your usual medical care.

المواقع (40)

  • جامعة ألاباما في برمنغهام
    الرمز البريدي المؤكد
    برمنغهام، الولايات المتحدة· منسحب
  • Arizona Arthritis & Rheumatology Associates - Glendale
    الرمز البريدي المؤكد
    غلينديل، الولايات المتحدة· التوظيف
  • Arizona Arthritis & Rheumatology Associates (AARA), P.C. - Mesa
    الرمز البريدي المؤكد
    ميسا، الولايات المتحدة· التوظيف
  • American Institute of Research
    الرمز البريدي المؤكد
    لوس أنجلوس، الولايات المتحدة· منسحب
  • TriWest Research Associates
    الرمز البريدي المؤكد
    سان دييغو، الولايات المتحدة· التوظيف
  • Valiance Clinical Research - Tarzana
    الرمز البريدي المؤكد
    Tarzana, United States· التوظيف
  • Hillcrest Medical Research
    الرمز البريدي المؤكد
    DeLand, United States· التوظيف
  • SIMEDHealth
    الرمز البريدي المؤكد
    غينزفيل، الولايات المتحدة· التوظيف
  • University of Florida Health Jacksonville
    الرمز البريدي المؤكد
    جاكسونفيل، الولايات المتحدة· التوظيف
  • Well Pharma Medical Research
    الرمز البريدي المؤكد
    ميامي، الولايات المتحدة· التوظيف
  • Clinical Research of West Florida
    الرمز البريدي المؤكد
    تامبا، الولايات المتحدة· التوظيف
  • Arthritis Center of North Georgia - Gainesville
    الرمز البريدي المؤكد
    غينزفيل، الولايات المتحدة· التوظيف

أسئلة شائعة

What is gout?

Gout is a type of painful arthritis caused by too much uric acid in the body, leading to sudden attacks of swollen, red, and very tender joints.

ما هو "العلاج الوهمي"؟

A placebo is a dummy tablet that looks like the real study drug but contains no active medicine. It helps researchers understand if the new drug truly works.

How long will I take the study tablets for?

You will take the study tablets twice a day for seven days.

Can I take my usual pain relief during the study?

During the main treatment period, you generally won't be able to take other pain medication or anti-inflammatory drugs, but you will be provided with rescue medication if needed.

What happens after the study treatment finishes?

You will have follow-up visits to check your progress and safety, with monitoring continuing up to about five weeks after you start the study.

كيفية معرفة المزيد

Philip Piscitelli

تحدث دائمًا إلى طبيبك العام أو الأخصائي قبل اتخاذ قرار بالمشاركة في دراسة.

هل أنت مهتم بالمشاركة؟

سجل اهتمامك

شارك تفاصيلك وفريق البحث لـ "Study of Dapansutrile Tablets in Subjects With an Acute Gout… "سيتواصل معك إذا كنت مؤهلاً. تحدث دائمًا إلى طبيبك قبل الموافقة على المشاركة.

نقاش

مناقشة المجتمع

مدعوم من منتدانا في community.patient.info. يرجى التحلي بالاحترام — هذه ليست نصيحة طبية.